ASPERGILLUS EIA GALACTOMANNAN TEST
-
Test Code
309
-
CPT Code
87305
-
Clinical Significance
Various chronic Aspergillus pathologies may be found in immunocompetent subjects, and their diagnosis often proves difficult. A process of mold sensitization is at the root of allergic manifestations such as asthma, allergic broncho-pulmonary aspergillosis (ABPA), which represents the most exacerbated clinical form. Aspergilloma represents the most typical non-allergic chronic pathology that is the result of colonization of a preexistent pulmonary cavity by fungal mycelia forming an Aspergillus ball. The PlateliaTM Aspergillus IgG assay, used to detect class G immunoglobulins directed against a recombinant purified antigen of Aspergillus, represents a tool for diagnostic assistance of these chronic forms of aspergillosis that are observed in immunocompetent subjects.
-
Methodology
- Platelia™ Aspergillus EIA immunoenzymatic sandwich microplate assay, cleared by the FDA for the detection of galactomannan in serum or BALF.
- Test validated at MiraVista Diagnostics for CSF specimens.
-
Limitations
The result is not intended to be used as the sole means for clinical diagnosis or patient management decisions.
False positives can be caused by:
- Piperacillin-tazobactam, amoxicillin/clavulanic acid
- PLASMA-LYTE and other fluids containing sodium gluconate. Patients must be off PLASMA-LYTE for at least 3 days before collection.
- Infection with Penicillium, Alternaria, Paecilomyces, Fusarium Geotrichum, Histoplasma, and Blastomyces, or airway colonization with above organisms
*Antifungal therapy may cause false negative results in patients with aspergillosis
*Cross-reactions in CSF can occur with Histoplasma spp., Blastomyces spp., Cryptococcus neoformans, and Pseudomonas aeruginosa. -
Specimen Collection
- Serum: Separated from clot in a leak-proof container.
- EDTA plasma: Separated from clot in a leak-proof container. (Reported with rare specimen comment applied.)
- CSF/BAL: Submit CSF and BAL in a sterile leak-proof container.
- New York approved for Serum, BAL, and CSF samples.
-
Minimum Specimen Requirements
Serum/EDTA Plasma/CSF/BAL: 0.8 mL
-
Specimen Stability
CSF:
- Room Temperature: 30 days
- Refrigerated: 30 days
- Frozen: 60 days
Serum/BAL/EDTA Plasma:
- Room Temperature: 48 hours
- Refrigerated: 5 days
- Frozen: 5 months
-
Specimen Rejection
- If specimen is too viscous to pipette.
- Nasal washings, plasma from any tube other than EDTA.
- Samples in fixative, transport media or PLASMA-LYTE.
-
Transport Temperature
Refrigerated/ Frozen
-
Shipping
Ship on dry ice for next day service. Frozen ice packs may be substituted if sample is shipped the day of the collection. Monday – Friday delivery.
-
Turnaround Time
Serum/EDTA Plasma/CSF/BAL: Same Day
*New positives my require confirmation
**Test Set up: Samples for Antigen testing received by 10:30AM will have same day test set up. Positive samples may require confirmation which could extend turnaround time. Serum & CSF specimens are pretreated to improve sensitivity, which can add one day to turnaround time.
-
Reference Range
Negative
-
Interpretative Information
Negative: <0.5
Results are reported as numeric values (Index) which are interpreted as positive or negative
-
Additional Information
Platelia™ is a registered trademark of BioRad